The impact of drug-related QT prolongation on FDA regulatory decisions

被引：29

作者：

Park, Eunjung ^{[1
]}

Willard, James ^{[1
]}

Bi, Daoqin ^{[1
]}

Fiszman, Monica ^{[1
]}

Kozeli, Devi ^{[1
]}

Koerner, John ^{[1
]}

机构：

[1] US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 168卷 / 05期

关键词：

QT prolongation; Safety warning; Drug approval;

D O I：

10.1016/j.ijcard.2013.07.136

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：4975 / 4976

页数：2

共 50 条

[1] Clinical relevance and management of drug-related QT interval prolongation
Crouch, MA
Limon, L
Cassano, AT
[J]. PHARMACOTHERAPY, 2003, 23 (07): : 881 - 908
[2] Clinical relevance of SCN5A heterozygous mutations in drug-related QT prolongation
Rutigliani, Carola
Ciconte, Giuseppe
Micaglio, Emanuele
Monasky, Michelle
Benedetti, Sara
Casari, Giorgio Nevio
Locati, Emanuela Teresina
Pappone, Carlo
[J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 195 - 195
[3] Drug-induced QT interval prolongation: regulatory perspectives and drug development
Shah, RR
[J]. ANNALS OF MEDICINE, 2004, 36 : 47 - 52
[4] FDA weighs communicating drug-related risk to patients
Stephenson, J
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (06): : 515 - 515
[5] Drug-induced prolongation of the QT interval: why the regulatory concern?
Shah, RR
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (02) : 119 - 124
[6] Drug-induced prolongation of the QT interval: why the regulatory concern?
Shah, R.
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 53 - 53
[7] Task force studying significance of drug-related QT interval
不详
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (06)
[8] Drug induced QT prolongation
Altmann, David
Eggmann, Urs
Ammann, Peter
[J]. WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (5-6) : 128 - 135
[9] The impact of drug-induced qt interval prolongation on drug discovery and development
Fermini, B
Fossa, AA
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (06) : 439 - 447
[10] The impact of drug-induced QT interval prolongation on drug discovery and development
Bernard Fermini
Anthony A. Fossa
[J]. Nature Reviews Drug Discovery, 2003, 2 : 439 - 447

← 1 2 3 4 5 →